Porton Pharma Solutions Ltd. (SHE:300363)
China flag China · Delayed Price · Currency is CNY
15.63
+0.97 (6.62%)
May 20, 2026, 12:49 PM CST

Porton Pharma Solutions Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
7,94812,5538,60213,73522,30548,697
Market Cap Growth
6.62%45.93%-37.37%-38.42%-54.20%145.68%
Enterprise Value
8,21713,1069,40313,24920,59848,168
Last Close Price
14.6623.1415.7024.2438.0883.17
PE Ratio
64.74130.30-51.4711.1292.95
Forward PE
39.6268.7654.1427.0712.6371.85
PS Ratio
2.273.672.863.753.1715.68
PB Ratio
1.452.281.592.253.4511.63
P/TBV Ratio
1.652.611.852.624.1313.64
P/FCF Ratio
16.8427.03--16.03-
P/OCF Ratio
11.8016.5821.2121.838.70101.42
PEG Ratio
-0.760.760.760.760.76
EV/Sales Ratio
2.343.833.123.612.9315.51
EV/EBITDA Ratio
14.0727.2992.3722.828.4066.91
EV/EBIT Ratio
51.99102.31-45.399.2986.65
EV/FCF Ratio
17.4128.22--14.81-
Debt / Equity Ratio
0.270.280.360.320.140.18
Debt / EBITDA Ratio
2.552.7611.023.080.370.99
Debt / FCF Ratio
3.153.25--0.66-
Net Debt / Equity Ratio
0.030.020.090.00-0.30-0.11
Net Debt / EBITDA Ratio
0.280.214.730.01-0.79-0.66
Net Debt / FCF Ratio
0.300.22-5.66-0.01-1.381.60
Asset Turnover
0.410.390.330.380.840.56
Inventory Turnover
3.233.153.102.764.103.11
Quick Ratio
1.271.251.371.941.471.12
Current Ratio
1.851.821.902.631.811.52
Return on Equity (ROE)
1.14%0.56%-6.36%2.79%36.34%12.55%
Return on Assets (ROA)
1.15%0.92%-1.54%1.87%16.59%6.28%
Return on Invested Capital (ROIC)
1.63%0.82%-3.73%3.90%46.32%15.82%
Return on Capital Employed (ROCE)
2.40%1.90%-3.20%3.70%31.10%12.50%
Earnings Yield
1.62%0.77%-3.35%1.94%8.99%1.08%
FCF Yield
5.94%3.70%-0.99%-3.65%6.24%-0.61%
Dividend Yield
0.61%0.39%-2.01%2.90%0.23%
Payout Ratio
21.14%31.25%-234.79%6.44%15.80%
Buyback Yield / Dilution
-11.15%1.42%0.31%-0.21%-0.62%0.11%
Total Shareholder Return
-10.54%1.81%0.31%1.80%2.28%0.34%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.